Nothing Special   »   [go: up one dir, main page]

Balogun et al., 2018 - Google Patents

Sero-Prevalence of Helicobacter pylori and Pre-Hospital Medication among Nigerians with and without Symptoms Suggestive of Peptic Ulcer in Maiduguri

Balogun et al., 2018

View PDF
Document ID
12127581317531198439
Author
Balogun S
Egwu M
Akanmu A
Okon K
Publication year
Publication venue
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS)

External Links

Snippet

The present study examined the sero-prevalence of Helicobacter pylori and pre-hospital medication among subjects with and without symptoms suggestive of peptic ulcer in Maiduguri, Northeast Nigeria. The specific objectives were to establish a preliminary …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/062—Gastritis or peptic ulcer disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans

Similar Documents

Publication Publication Date Title
Ximénez et al. Reassessment of the epidemiology of amebiasis: state of the art
Logan et al. Simplified single sample 13Carbon urea breath test for Helicobacter pylori: comparison with histology, culture, and ELISA serology.
Tonkic et al. Epidemiology and Diagnosis of H elicobacter pylori Infection
Olokoba et al. Helicabacter pylori Infection in Nigerians with Dyspepsia
Agreus et al. Dyspepsia: current understanding and management
Bellentani et al. A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room
Ibekwe et al. Baseline Salmonella agglutinin titres in apparently healthy freshmen in Awka, South Eastern, Nigeria
De Silva et al. Chronic Strongyloides stercoralis infection in Laotian immigrants and refugees 7–20 years after resettlement in Australia
Dash et al. Role of CSF CK, LDH, GGTP enzyme levels in diagnostic and prognostic evaluation of meningitis
Galbán et al. Endoscopic findings and associated risk factors in primary health care settings in Havana, Cuba
Holtmann et al. Antibody Response to SpecificH. PyloriAntigens in Functional Dyspepsia, Duodenal Ulcer Disease, and Health
Mazzoleni et al. Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study
El Khadir et al. Detection of Helicobacter pylori urease antigen in saliva in patients with different gastric H. pylori status
Segamwenge et al. The utility of the Helicobacter pylori stool antigen test in managing dyspepsia: an experience from a low resource setting
Triantafillidis et al. Helicobacter pylori infection in hospital workers over a 5-year period: correlation with demographic and clinical parameters
Balogun et al. Sero-Prevalence of Helicobacter pylori and Pre-Hospital Medication among Nigerians with and without Symptoms Suggestive of Peptic Ulcer in Maiduguri
Guelrud et al. Prevalence of Helicobacter pylori in neonates and young infants undergoing ERCP for diagnosis of neonatal cholestasis
Rui et al. A half-century studies on epidemiological features of ancylostomiasis in China: a review article
Kuntoji et al. A prospective study of proportion of Helicobacter pylori infection in patients presenting with dyspeptic symptoms in S. Nijalingappa medical college and HSK Hospital, Bagalkot
Alsaimary et al. Clinical findings and prevalence of helicobacter pylori in patients with gastritis B in Al-basrah governorate
Naqvi et al. Upper Gastrointestinal Endoscopic Outcomes in Patients with Gastrointestinal Symptoms: Retrospective Analysis at a Tertiary Care Hospital
Patel et al. Assessment of fecal calprotectin and fecal occult blood as point-of-care markers for soil-transmitted helminth attributable intestinal morbidity in a case-control substudy conducted in Côte d'Ivoire, Lao PDR and Pemba Island, Tanzania
Badeli et al. Prevalence of hematuria and proteinuria in healthy 4 to 6 year old children in daycare centers of Rasht (Northern Iran)
Saidu et al. Seroprevalence of Helicobacter pylori among adult in Sokoto metropolis
Gashau et al. Blind Helicobacter pylori treatment in dyspeptics in a high prevalence area